Is DIVA Laboratories, Ltd. (4153.TWO) a Buy, Sell, or Hold?
TWO : 4153.TWO
DIVA Laboratories, Ltd.
$31.7 TWD
$0 (0.0%)
- Volume
- 5.26K
- Average Volume
- 23.26K
- Market Capitalization
- $1.86B
- P/E Ratio
- 19.57
- Dividend Yield
- 6.31%
- Price Target
- Year High
- $41.70
- Year Low
- $29.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $1.22
- Current Ratio
- $2.41
Company Overview
TWO
Chen Gene
Medical - Diagnostics & Research
Healthcare
4153.TWO
154
TW
TWD
Liquidity Metrics
0.00
2.41
1.80
1.10
1.22
Sales & Valuation
$868.84M
2.08
1.94
82.17
0.38
Profitability
$1.54
$90.54M
10.72%
12.29%
9.77%
6.55%
P/E Metrics
19.57
2.97
2.97
Analyst Price Target & Rating
4/5
0 Analysts
%
Financial Health Scores
3.75
4/9
$703.09M
$1.47B
$498.7M
$102.16M
Key Metrics (TTM)
No key metrics data available.
Company Executives
| Name | Title |
|---|---|
| Jun Xian Li | Director of the Information Department |
| Chen Gene | Vice Chairman & CEO |
| James Chen | Vice President & Chief Technology Officer |
| Peter Chang | Chief Operating Officer |
| Kenneth Chen | Chief SO |
| Jian Gen Zhang | Deputy General Manager of the Development Department |
| Su Ru Lin | Accounting Supervisor |
Poll Results
No votes yet today — be the first to share your view!
About DIVA Laboratories, Ltd. (TWO:4153.TWO) Stock
DIVA Laboratories, Ltd. specializes in the global provision of advanced display technologies. Its comprehensive product lineup caters to critical environments, including specialized endo/surgical displays designed to render both static and dynamic imagery with precision for hybrid and integrated operating theaters, as well as crucial control room applications. Furthermore, DIVA offers a range of color and monochrome monitors tailored for high-accuracy radiology and broader medical imaging purposes. Beyond healthcare, the company develops interactive touch displays and human-machine interface (HMI) solutions, alongside robust medical and industrial enclosures. DIVA also serves original design manufacturers (ODMs) and original equipment manufacturers (OEMs) with custom display units, in addi ... tion to a broader portfolio of video solutions. Established in 1995, DIVA Laboratories, Ltd. maintains its corporate headquarters in New Taipei City, Taiwan.
Frequently Asked Questions
-
What is the current DIVA Laboratories, Ltd. (4153.TWO) stock price?
-
DIVA Laboratories, Ltd.(TWO:4153.TWO) stock price is $31.7 in the last trading session. During the trading session, 4153.TWO stock reached the peak price of $41.7 while $29 was the lowest point it dropped to. The percentage change in 4153.TWO stock occurred in the recent session was 0.0% while the dollar amount for the price change in 4153.TWO stock was $0.
-
4153.TWO's industry and sector of operation?
-
The TWO listed 4153.TWO is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.
-
Who are the executives of 4153.TWO?
-
Jun Xian Li | Director of the Information Department
Chen Gene | Vice Chairman & CEO
James Chen | Vice President & Chief Technology Officer
Peter Chang | Chief Operating Officer
Kenneth Chen | Chief SO -
How many employees does 4153.TWO have?
-
Number of 4153.TWO employees currently stands at 154. 4153.TWO operates from No. 351, Zhongshan Rd., New Taipei City, TP 235, TW.
-
Link for 4153.TWO official website?
-
Official Website of 4153.TWO is: https://www.diva.com.tw
-
How do I contact 4153.TWO?
-
4153.TWO could be contacted at phone #886 2 2226 8631 and can also be accessed through its website. 4153.TWO operates from No. 351, Zhongshan Rd., New Taipei City, TP 235, TW.
-
How many shares of 4153.TWO are traded daily?
-
The average number of 4153.TWO shares traded daily for last 3 months was 23.26K.
-
What is the market cap of 4153.TWO currently?
-
The market value of 4153.TWO currently stands at $1.86B with its latest stock price at $31.7